Andrew Schenker

Meetings with Centene Corp (NYSE: CNC) management in Asia and the June Investor Day boosted confidence in the stability of the HNT platform and the company’s long-term pipeline, Morgan Stanley’s Andrew Schenker said in a report. He upgraded the company from Equal-weight to Overweight...

Tenet Healthcare Corp (NYSE: THC) shares are down more than 10 percent year-to-date despite a favorable outlook, an analyst said Tuesday. Worries regarding a pending Supreme Court decision on the Affordable Care Act, as well as unmet high expectations have pressured the hospital chain since it...

In a report published Monday, Morgan Stanley analyst Andrew Schenker reiterated an Equal-Weight rating on LifePoint Hospitals (NASDAQ: LPNT), but removed the $76.00 price target. In the report, Morgan Stanley noted, “Our updated 2015 EBITDA est. of $700M reflects improving utilization trends and...

Hospital companies with significant operations in the Dallas-Fort Worth region could see potential patients scared away by recent reports of Ebola, an analyst said Thursday. Potential hospital patients in the region "might exercise greater restraint on hospital visits due to fear of...

In a report published Friday, Morgan Stanley analyst Andrew Schenker reiterated an Equal-Weight rating on Molina Healthcare, Inc. (NYSE: MOH). In the report, Morgan Stanley noted, “ While MOH did not outright lower its initial 2014 EPS guidance of $1.65 to $2.15, there are a number of elements that...

In a report published Monday, Morgan Stanley analyst Andrew Schenker initiated coverage on Adeptus Health (NYSE: ADPT) with an Equal-Weight rating. In the report, Morgan Stanley noted, “We are initiating on ADPT with an EW rating on a balanced risk reward. While the extended development pipeline...

In a report published Thursday, Morgan Stanley analyst Andrew Schenker reiterated an Overweight rating on HCA Holdings (NYSE: HCA), and raised the price target from $65.00 to $67.00. In the report, Morgan Stanley noted, “HCA raised its EBITDA guidance to $7B to $7.15B reflecting TX Medicaid...

In a report published Monday, Morgan Stanley analyst Andrew Schenker reiterated an Equal-Weight rating on Centene (NYSE: CNC). In the report, Morgan Stanley noted, “CNC signaled that it would update its current EPS guidance during its 2Q earnings call to reflect recently announced acquisitions. The...

In a report published Wednesday, Morgan Stanley analyst Andrew Schenker reiterated an Overweight rating and $99.00 price target on CIGNA (NYSE: CI). In the report, Morgan Stanley noted, “Expect continued improvement in Medicare. Cigna may not see the full benefit of some of the triage activities...

In a report published Tuesday, Morgan Stanley analyst Andrew Schenker reiterated an Overweight rating on Aetna (NYSE: AET), but removed the $83.00 price target. In the report, Morgan Stanley noted, “While CEO Bertolini suggested utilization and claims severity for initial exchange enrollment was...

In a report published Thursday, Morgan Stanley analyst Andrew Schenker reiterated an Overweight rating on Envision Healthcare Holdings (NYSE: EVHC), but removed the $33.00 price target. In the report, Morgan Stanley noted, “EVHC reported 1Q14 adj. EBITDA of $110M vs. consensus of $111.5M and MS'...

In a report published Monday, Morgan Stanley analyst Andrew Schenker reiterated an Equal-Weight rating on LifePoint Hospitals (NASDAQ: LPNT). In the report, Morgan Stanley noted, “Early benefits from reform exceeded expectations with a ~26% decline in self-pay admissions. LPNT now expects reform...

In a report published Friday, Morgan Stanley analyst Andrew Schenker reiterated an Equal-Weight rating on Surgical Care Affiliates (NASDAQ: SCAI). In the report, Morgan Stanley noted, “SCAI issued 2014 Adjusted EBITDA-NCI guidance of $154M to $158M, which was in-line with MS and consensus at $154M...